NeoGenomics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NeoGenomics and other ETFs, options, and stocks.

About NEO

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T.

CEO

Anthony P. Zook

CEOAnthony P. Zook

Employees

2,200

Employees2,200

Headquarters

Fort Myers, Florida

HeadquartersFort Myers, Florida

Founded

1998

Founded1998

Employees

2,200

Employees2,200

NEO Key Statistics

Market cap

1.31B

Market cap1.31B

Price-Earnings ratio

-12.60

Price-Earnings ratio-12.60

Dividend yield

—

Dividend yield—

Average volume

6.13M

Average volume6.13M

High today

$10.38

High today$10.38

Low today

$9.20

Low today$9.20

Open price

$10.08

Open price$10.08

Volume

1.69M

Volume1.69M

52 Week high

$19.12

52 Week high$19.12

52 Week low

$4.72

52 Week low$4.72

NEO News

Nasdaq 8h

NEO Crosses Above Average Analyst Target

In recent trading, shares of NeoGenomics Inc (Symbol: NEO) have crossed above the average analyst 12-month target price of $10.00, changing hands for $10.28/sha...

Nasdaq 1d

NeoGenomics Moves 6.3% Higher: Will This Strength Last?

NeoGenomics (NEO) shares soared 6.3% in the last trading session to close at $9.97. The move was backed by solid volume with far more shares changing hands than...

Nasdaq 4d

NEO Crosses Above Key Moving Average Level

In trading on Monday, shares of NeoGenomics Inc (Symbol: NEO) crossed above their 200 day moving average of $9.36, changing hands as high as $9.62 per share. Ne...

Analyst ratings

53%

of 15 ratings

Buy

40%

Hold

53.3%

Sell

6.7%

People also own

Based on the portfolios of people who own NEO. This list is generated using Robinhood data, and it’s not a recommendation.